Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Cash from Investing Activities (2021 - 2026)

Valneva SE (VALN) posted Cash from Investing Activities of $321955.1 for Q1 2026, up 204.77% sequentially from -$307307.5 in Q4 2025, and up 131.85% YoY from $138863.8 in Q1 2025.

Analysis

Valneva SE (VALN) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Valneva SE has reported Cash from Investing Activities for 6 years, with the latest figure at $321955.1 in Q1 2026.

  • Quarterly Cash from Investing Activities rose 131.85% year-over-year to $321955.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$525913.1 (up 95.59% YoY) and the FY2025 annual result came in at -$2.0 million, down 102.39% from the prior year.
  • Cash from Investing Activities advanced to $321955.1 in Q1 2026 per VALN's latest filing, from -$307307.5 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $94.2 million in Q1 2024 and troughed at -$17.6 million in Q4 2023.
  • A 5-year average of $1.7 million and a median of -$1.0 million in 2025 frame the typical range for Cash from Investing Activities.
  • The widest YoY moves for Cash from Investing Activities: up 2564.61% in 2024, down 756.9% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$6.7 million in 2022, then slumped by 161.86% to -$17.6 million in 2023, then surged by 128.54% to $5.0 million in 2024, then plunged by 106.13% to -$307307.5 in 2025, then soared by 204.77% to $321955.1 in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $321955.1, -$307307.5, and $230303.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 413,800.82
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 413,800.82
Mar 31, 2026 321,955.05
Dec 31, 2025 -307,307.49
Sep 30, 2025 230,303.85
Jun 30, 2025 -770,864.55
Mar 31, 2025 -1.01 Mn
Dec 31, 2024 5.01 Mn
Sep 30, 2024 -16.89 Mn
Jun 30, 2024 963,814.38
Mar 31, 2024 94.20 Mn
Dec 31, 2023 -17.56 Mn
Sep 30, 2023 7.21 Bn
Jun 30, 2023 -7.22 Bn
Mar 31, 2023 -3.82 Mn
Dec 31, 2022 -6.70 Mn
Sep 30, 2022 -6.54 Mn
Jun 30, 2022 -6.99 Mn
Mar 31, 2022 -10.60 Mn
Dec 31, 2021 -26.60 Mn
Sep 30, 2021 -35.34 Mn